The Illness Density Index (IDI): A longitudinal measure of treatment efficacy

Clinical Trials

Volumn 9, Issue 5, 2012, Pages 596-604

  Kelley, Mary E ^a   Franco, Alexandre R ^b,c   Mayberg, Helen S ^b   Holtzheimer, Paul E ^b,d  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DENSITY; DEPRESSION; EXAMINATION; FEMALE; HAMILTON SCALE; HUMAN; ILLNESS DENSITY INDEX; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RELAPSE; REMISSION; SENSITIVITY ANALYSIS; SYMPTOM; THERAPY;

ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; MODELS, STATISTICAL; PATIENT ACUITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84867511182     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774512450099     Document Type: Article

References (14)

1. Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1999 ; 60: 7-11
2. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: A focus on treatment-resistant depression. J Clin Psychiatry. 2001 ; 62: 5-9
3. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study. Biol Psychiatry. 2005 ; 58: 355-63
4. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005 ; 66: 1097-104
5. Lozano AM, Mayberg HS, Giacobbe P, et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008 ; 64: 461-67
6. Greenberg BD, Gabriels LA, Malone DA, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: Worldwide experience. Mol Psychiatry. 2010 ; 15: 64-79
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 ; 23: 56-62
8. Berry DA, Ayers GD. Symmetrized percent change for treatment comparisons. Am Stat. 2006 ; 60: 27-31
9. Mallinckrodt CH, Kaiser CJ, Watkin JG, Molenberghs G, Carroll RJ. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA. Clin Trials. 2004 ; 1: 477-89
10. Lutz W, Stulz N, Kock K. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders. J Affect Disord. 2009 ; 118: 60-68
11. Uher R, Muthen B, Souery D, et al. Trajectories of change in depression severity during treatment with antidepressants. Psychol Med. 2010 ; 40: 1367-77
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 ; 143: 29-36
13. Heldens JG, Weststrate MW, van den Hoven R. Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines-a retrospective analysis of three independent field trials. J Immunol Methods. 2002 ; 264: 11-17
14. Fekedulegn DB, Andrew ME, Burchfiel CM, et al. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med. 2007 ; 69: 651-59